Skip to main content
. 2016 Mar 18;100(12):1640–1645. doi: 10.1136/bjophthalmol-2015-308090

Figure 1.

Figure 1

The proportion of eyes that were graded as having an active choroidal neovascular membrane throughout the 12 months after switching treatment.